How much is Imbria Pharmaceuticals worth in 2026?

Imbria Pharmaceuticals has a current valuation of $131.7M based on their Later Stage VC round and secondary market data.

How much funding has Imbria Pharmaceuticals raised?

Imbria Pharmaceuticals has raised $151.9M in total funding across 1 funding rounds.

Imbria Pharmaceuticals

Drug DiscoveryWebsite

Imbria Pharmaceuticals valuation and funding history | Last updated: December 16, 2025 | 1 funding rounds

Current Valuation

$131.7M

As of December 16, 2025

Total Funding Raised

$151.9M

Across 1 round

Last Round

Later Stage VC

$66.7M

Last Funding

Dec 2025

Funding date

Capital Efficiency

0.87x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 16, 2025	Later Stage VC (Series B)	$66.7M	N/A	-

Valuation Analysis

Current Valuation Metrics

Imbria Pharmaceuticals is currently valued at $131.7M as of December 16, 2025. The company has raised a total of $151.9M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 0.87x, Imbria Pharmaceuticals has achieved a valuation that is 0.87 times the total capital raised.

Track Imbria Pharmaceuticals Valuation Updates

Get notified when Imbria Pharmaceuticals raises new funding or valuation changes

Explore More Data

Detailed analysis for Imbria Pharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Imbria Pharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is Imbria Pharmaceuticals Worth in 2026?

Imbria Pharmaceuticals is a leading private company in the Drug Discovery sector. Track Imbria Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Imbria Pharmaceuticals Valuation is Determined

Private company valuations like Imbria Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.